AKR1C3-IN-5
AKR1C3-IN-5 (Compound 6e) is a potent inhibitor of AKR1C3. AKR1C3 enzyme is overexpressed in hormone-dependent prostate and breast tumors. AKR1C3-IN-5 derived from drupanin, which exhibits half-maximal inhibitory concentration (IC50) of 9.6 ± 3 μM and selectivity index (SI) of 5.5 against MCF-7 cells[1].
Product Specifications
CAS Number
2839142-93-5
UNSPSC
12352005
Target
Aldose Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/akr1c3-in-5.html
Solubility
10 mM in DMSO
Smiles
CC(OC1=CC=C(C=C1C/C=C(C)\C)/C=C/C(N[C@H](C(OCC2=CC=CC=C2)=O)CCCCNC(OC(C)(C)C)=O)=O)=O
Molecular Formula
C34H44N2O7
Molecular Weight
592.72
References & Citations
[1]Rodrigues DM, et al. Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis. Bioorg Med Chem. 2021 Oct 1;47:116372.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PerCP Anti-Human CD45RA Antibody[HI100]](https://cdn.genprice.uk/products/763/68dd14a6061270361e7d1d7d/imageurl/e-ab-f1052f.webp)
E-AB-F1052F-03 2x 100 Tests
PerCP Anti-Human CD45RA Antibody[HI100]
Sign In for Pricing
View Details 
